The Effect of Potassium Canrenoate (Mineralocorticoid Receptor Antagonist) on the Markers of Inflammation in the Treatment of COVID-19 Pneumonia and Fibrosis—A Secondary Analysis of Randomized Placebo-Controlled Clinical Trial

In March 2020, the World Health Organization (WHO) announced a global pandemic of coronavirus disease 2019 (COVID-19) that presented mainly as an acute infection of the lower respiratory tract (pneumonia), with multiple long-term consequences, including lung fibrosis. The aim of this study was to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Karolak, Igor, Hrynkiewicz, Rafał, Niedźwiedzka-Rystwej, Paulina, Lechowicz, Kacper, Sieńko, Jerzy, Szylińska, Aleksandra, Dabrowski, Wojciech, Kotfis, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532011/
https://www.ncbi.nlm.nih.gov/pubmed/37762549
http://dx.doi.org/10.3390/ijms241814247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532011/
https://www.ncbi.nlm.nih.gov/pubmed/37762549
http://dx.doi.org/10.3390/ijms241814247

Ejemplares similares